Guardant Health vs Progyny
Progyny is the larger business, with $1.29bn of revenue in fiscal 2025 against $982m for Guardant Health (1.3 times as much). Guardant Health grew faster (32.9% against 10.4%). Progyny kept more of each dollar of sales as profit: a net margin of 4.5% against -42.4%.
| Latest fiscal year | Guardant HealthGH, 2025 | ProgynyPGNY, 2025 |
|---|---|---|
| Revenue | $982m | $1.29bn |
| Revenue growth | 32.9% | 10.4% |
| Net income | −$416m | $58.5m |
| Operating margin | -44.5% | — |
| Net margin | -42.4% | 4.5% |
| Return on equity | — | 12.5% |
| Free cash flow | −$233m | $192m |
| Cash | $378m | $112m |
| Total debt | $1.50bn | $0 |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $45.0m | $81.7m |
| Employees | 2,506 | 1,000 |
| Market value | $23.34bn | $2.25bn |
| Price vs our value range | — | Within our value range |
| Moat score | 8 (Weak) | 43 (Weak) |
| Insider trades, 12 months | 1 buys, 141 sales | 1 buys, 25 sales |